Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-28
2005-06-28
Desai, Rita (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S381000, C548S400000, C548S517000, C548S527000
Reexamination Certificate
active
06911461
ABSTRACT:
The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I,wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals.The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
REFERENCES:
patent: 2836599 (1958-05-01), Frankel et al.
patent: 4943639 (1990-07-01), Gobert et al.
patent: 6784197 (2004-08-01), Differding et al.
patent: 1309692 (1973-03-01), None
patent: 99/13911 (1999-03-01), None
Prous: Drugs of the Future, ES, Barcelona, vol. 19, No. 2, pp. 111-113 (1994).
Fischer et al.: Pharmazie, vol. 46, pp. 359-360 (1991).
Chemical Abstracts, vol. 95, No. 3, p. 661, Abstract No. 24693r (1981).
Glozman et al.: Khim.-Farm. ZH., vol. 14, No. 11, pp. 43-48 (1980).
Banfi et al.: Farmaco, Ec. Sci., vol. 39, No. 1, pp. 16-22 (1984).
Pellegata et al.: Farmaco, Ec. Sci., vol. 36, No. 10, pp. 845-855 (1981).
Pinza et al.: Farmaco, Ed. Sci., vol. 33, No. 2, pp. 130-141 (1978).
Pifferi et al.: Farmaco, Ed. Sci., vol. 32, No. 8, pp. 602-613 (1977).
Sugawara et al.: Arzneimittel Forschung. Drug Research, Editio Cantor. Aulendorf, DE, vol. 44, No. 1, pp. 211-213 (1994).
Vettinger et al.: Liebigs Ann. Chem., vol. 2, pp. 195-201 (1990).
Elliott et al.: Journal of Medicinal Chemistry, vol. 37, No. 11, pp. 1562-1568 (1994).
Lehmann et al.: Heterocycles, vol. 51, No. 6, pp. 1389-1400 (1999).
Almeida et al.: Tetrahedron: Asymmetry, vol. 3, No. 11, pp. 1431-1440 (1992).
Chemical Abstracts, vol. 52, No. 10, Abstract No. 2007i (1958).
Koelsch et al., J. Org. Chem., vol. 21, pp. 1211-1213 (1956).
Database Beilstein Online!, Beilstein Institute for Organic Chemistry, Database accession No. 13551.
Sugasawa: Chem. Zentralbl., vol. 98, No. II, p. 932 (1927).
Thorsett et al., Journal of Medicinal Chemistry, vol. 29, No. 2, pp. 251-260 (1986).
Database Beilstein Online!, Beilstein Institute for Organic Chemistry, Database accession No. 6922620.
Keusenkothen et al.: J. Chem. Soc. Perkin Trans1, vol. 17, pp. 2485-2492 (1994).
Thaisrivongs et al., Journal of Medicinal Chemistry, vol. 31, No. 7, pp. 1369-1376 (1988).
Glozman et al., 1981, CAS:95:24693.
Kometani et al., 1991, CAS:115:126869.
Differding Edmond
Kenda Benoît
Lallemand Bénédicte
Matagne Alain
Michel Philippe
Desai Rita
Shiao Robert
UCB S.A.
LandOfFree
2-oxo-1-pyrrolidine derivatives, processes for preparing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-oxo-1-pyrrolidine derivatives, processes for preparing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-oxo-1-pyrrolidine derivatives, processes for preparing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3460502